Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* All patients aged 18 years and above undergoing first ERCP procedure~Exclusion Criteria:~* Active acute pancreatitis,~* Lower end malignant bile duct block,~* Patients undergoing repeat procedures,including those with previous sphincterotomy~* Ongoing therapy with nitrates, calcium channel blockers, somatostatin or octreotide~* Patients with bleeding diathesis.~* Patients with chronic pancreatitis~* Patients with cardiac comorbidity

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Valdecoxib
- 2 (Type: ACTIVE_COMPARATOR): None
- 3 (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).